T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Roper Technologies
ROP
|
$795M |
| 2 |
Abbott
ABT
|
$750M |
| 3 |
Thermo Fisher Scientific
TMO
|
$746M |
| 4 |
Becton Dickinson
BDX
|
$730M |
| 5 |
Cigna
CI
|
$725M |
Top Sells
| 1 |
Salesforce
CRM
|
$1.32B |
| 2 |
Martin Marietta Materials
MLM
|
$959M |
| 3 |
Linde
LIN
|
$839M |
| 4 |
AbbVie
ABBV
|
$829M |
| 5 |
Intercontinental Exchange
ICE
|
$814M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 20.82% |
| 3 | Consumer Discretionary | 12.47% |
| 4 | Industrials | 10.66% |
| 5 | Financials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
KKR & Co
KKR
$121B
| $60.9M | 0.04% |
411,559
-2,342,728
| -85% | -$347M |
|
|
BPMC
377
DELISTED
Blueprint Medicines
BPMC
| $60.8M | 0.04% |
697,027
-51,665
| -7% | -$4.51M |
|
378
Cathay General Bancorp
CATY
$3.43B
| $60.4M | 0.04% |
1,268,030
+6,081
| +0.5% | +$290K |
|
379
DigitalBridge
DBRG
$2.04B
| $60.3M | 0.04% |
5,342,763
-7,221,911
| -57% | -$81.5M |
|
380
Vera Therapeutics
VERA
$1.54B
| $59.8M | 0.04% |
1,415,179
+431,178
| +44% | +$18.2M |
|
381
Five Star Bancorp
FSBC
$702M
| $59.8M | 0.04% |
1,988,396
-37,643
| -2% | -$1.13M |
|
382
AST SpaceMobile
ASTS
$11.4B
| $59.5M | 0.04% |
+2,820,984
| New | +$59.5M |
|
383
United Parks & Resorts
PRKS
$2.99B
| $59.3M | 0.04% |
1,055,026
+404,120
| +62% | +$22.7M |
|
384
Installed Building Products
IBP
$7.44B
| $59.2M | 0.04% |
338,081
+158,173
| +88% | +$27.7M |
|
385
Immunome
IMNM
$916M
| $58.4M | 0.04% |
5,499,954
-262,059
| -5% | -$2.78M |
|
386
Skechers
SKX
$9.5B
| $57.4M | 0.04% |
853,524
-116,435
| -12% | -$7.83M |
|
387
RenaissanceRe
RNR
$11.3B
| $57.3M | 0.04% |
230,183
-24,294
| -10% | -$6.04M |
|
|
CNTA
388
Centessa Pharmaceuticals
CNTA
$2.11B
| $57.3M | 0.04% |
3,418,600
-137,423
| -4% | -$2.3M |
|
389
Tetra Tech
TTEK
$9.48B
| $57.2M | 0.04% |
1,436,604
-1,069,926
| -43% | -$42.6M |
|
390
Red Rock Resorts
RRR
$3.7B
| $56.7M | 0.03% |
1,225,188
+38,620
| +3% | +$1.79M |
|
391
Xenon Pharmaceuticals
XENE
$3.02B
| $56.4M | 0.03% |
1,437,831
-65,977
| -4% | -$2.59M |
|
392
Progyny
PGNY
$1.94B
| $56.3M | 0.03% |
3,265,316
-164,729
| -5% | -$2.84M |
|
393
PBF Energy
PBF
$3.3B
| $56.2M | 0.03% |
2,116,396
+1,272,254
| +151% | +$33.8M |
|
394
Atmos Energy
ATO
$26.7B
| $56M | 0.03% |
401,819
+29,701
| +8% | +$4.14M |
|
395
Transcat
TRNS
$729M
| $54.8M | 0.03% |
518,597
+332,064
| +178% | +$35.1M |
|
396
Taylor Morrison
TMHC
$7.1B
| $54.4M | 0.03% |
888,647
-394,911
| -31% | -$24.2M |
|
397
Arcellx
ACLX
$4.03B
| $54.1M | 0.03% |
705,922
-238,716
| -25% | -$18.3M |
|
398
Upwork
UPWK
$2.15B
| $54M | 0.03% |
3,303,035
+1,534,078
| +87% | +$25.1M |
|
399
Voya Financial
VOYA
$7.38B
| $53.9M | 0.03% |
782,543
-505,654
| -39% | -$34.8M |
|
400
Crocs
CROX
$4.72B
| $53.7M | 0.03% |
490,544
+307,185
| +168% | +$33.6M |
|